What is the prevalence of Pemphigus?

Pemphigus is a group of rare, autoimmune blistering diseases with an estimated global prevalence ranging from 0.5 to 3.2 cases per 100,000 individuals, though rates vary significantly by region and ethnicity. Because symptoms can mimic other dermatological conditions, the true prevalence of Pemphigus is likely higher than current diagnostic data suggests due to frequent underdiagnosis or misdiagnosis.

How common is Pemphigus globally?

Pemphigus is classified as a rare disease. While global estimates suggest a prevalence of 0.5 to 3.2 per 100,000, these numbers are highly dependent on geography. For instance, the incidence rate—the number of new cases diagnosed per year—is generally cited between 0.1 and 0.5 per 100,000 people. However, in specific populations, such as individuals of Ashkenazi Jewish or Mediterranean descent, the incidence of Pemphigus is notably higher. It is important to note that these figures are estimates; because Pemphigus presents with lesions that may be confused with other skin conditions, many patients experience a significant "diagnostic delay," meaning they live with the disease for months or years before receiving an accurate clinical diagnosis.

Who is most likely to be affected by Pemphigus?

Epidemiological data regarding the demographics of Pemphigus show several consistent trends:

• Age of Onset: While Pemphigus can occur at any age, it most commonly manifests in adults between the ages of 50 and 60. Pediatric cases are considered extremely rare.


• Gender Distribution: Most clinical studies indicate that Pemphigus affects males and females with roughly equal frequency, though some regional studies suggest a slight female predominance.


• Ethnic Variation: There is a documented genetic predisposition in certain ethnic groups, particularly among Ashkenazi Jews, individuals of Mediterranean heritage, and those from parts of India, where the incidence is higher than in Northern European populations.

Why is it difficult to determine the exact prevalence of Pemphigus?

Accurately mapping the prevalence of Pemphigus is challenging due to the relative rarity of the condition and the complexity of its clinical presentation. Many general practitioners may not encounter a case of Pemphigus in their entire career, leading to initial misdiagnoses of simpler skin infections or rashes. Furthermore, there is no centralized global registry for Pemphigus, meaning researchers must rely on hospital-based data or insurance claims, which often exclude patients who have not yet accessed specialized care.

How does the DiseaseMaps community compare to clinical data?

At DiseaseMaps.org, we have 199 people with Pemphigus who have joined our community and shared their experiences. While this represents a small subset of the global population, these real-world data points are invaluable. They provide a unique perspective on the "patient journey," often highlighting the long time-to-diagnosis and the emotional burden of living with a chronic autoimmune condition that clinical statistics alone cannot fully capture. By connecting with others, patients can share insights on symptom management and finding specialized dermatologists, bridging the gap between clinical data and lived experience.

Next steps

• Consult a board-certified dermatologist or an immunodermatologist who specializes in autoimmune bullous diseases.


• Request a biopsy for direct immunofluorescence (DIF), which is the gold standard for confirming a diagnosis of Pemphigus.


• Join the DiseaseMaps.org community to connect with other patients and access shared resources.


• Keep a detailed log of your symptoms and potential triggers to share with your healthcare provider during follow-up visits.

Medical disclaimer: This content is for informational purposes only and does not constitute medical advice, diagnosis, or treatment; always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.

References

• Orphanet: Pemphigus vulgaris (ORPHA:677)


• NIH Genetic and Rare Diseases Information Center (GARD): Pemphigus


• OMIM (Online Mendelian Inheritance in Man): Pemphigus family of diseases


• International Pemphigus & Pemphigoid Foundation (IPPF)